Latest Institutional Sells of Acrivon Therapeutics, Inc. (ACRV)
This list provides information on the latest institutional transactions involving Acrivon Therapeutics, Inc. (ACRV) stock that were sells. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the sale has occurred.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-212K- 26.19% |
N/A
|
598K
$0
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-21K- 0.98% |
N/A
|
2.12M
$0
|
|
|
Feb 12, 2025
Q4 2024
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-13.5K- 44.47% |
N/A
|
16.9K
$0
|
|
|
Feb 14, 2025
Q4 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-12.4K- 48.01% |
N/A
|
13.4K
$0
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-8.18K- 24.07% |
N/A
|
25.8K
$0
|
|
|
Feb 13, 2025
Q4 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-2.99K- 62.86% |
N/A
|
1.77K
$0
|
|
|
Feb 06, 2025
Q4 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-2.41K- 2.08% |
N/A
|
114K
$0
|
|
|
Feb 14, 2025
Q4 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-2.38K- 3.09% |
N/A
|
74.6K
$0
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.18K- 3.29% |
N/A
|
34.7K
$0
|
|
|
Feb 12, 2025
Q4 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-714- 0.24% |
N/A
|
301K
$0
|
|
|
Feb 13, 2025
Q4 2024
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-35- 13.57% |
N/A
|
223
$0
|
|
|
Feb 04, 2025
Q4 2024
|
Cwm, LLC
|
SELL
|
- |
-5- 10.87% |
N/A
|
41
$0
|
|
|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-5- 0.03% |
N/A
|
17.8K
$0
|
|
| Q3 2024 | |||||||
|
Oct 10, 2024
Q3 2024
|
Exchange Traded Concepts, LLC
|
SELL
|
- |
-22.5K- 52.53% |
N/A
|
20.3K
$0
|
|
|
Nov 14, 2024
Q3 2024
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-8.94K- 7.36% |
N/A
|
112K
$0
|
|
| Q2 2024 | |||||||
|
Aug 14, 2024
Q2 2024
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-371- 30.24% |
N/A
|
856
$0
|
|
| Q1 2024 | |||||||
|
Apr 23, 2024
Q1 2024
|
Amalgamated Bank
New York, NY |
SELL
|
- |
-853- 69.29% |
N/A
|
378
$0
|
|
|
Apr 25, 2024
Q1 2024
|
Bank Of New York Mellon Corp
New York, NY |
SELL
|
- |
-382- 1.54% |
N/A
|
24.4K
$0
|
|
| Q4 2023 | |||||||
|
Feb 14, 2024
Q4 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-14.8K- 31.68% |
N/A
|
31.9K
$0
|
|
| Q3 2023 | |||||||
|
Nov 13, 2023
Q3 2023
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-78K- 25.64% |
N/A
|
226K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Nea Management Company, LLC
Timonium, MD |
SELL
|
- |
-51.4K- 10.68% |
N/A
|
430K
$0
|
|
| Q2 2023 | |||||||
|
Aug 14, 2023
Q2 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-1.31K- 24.34% |
N/A
|
4.06K
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-85- 9.2% |
N/A
|
839
$0
|
|